TScan Therapeutics, Inc. (TCRX) fundamentals chart
TCRXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 4/3089% below fair value
$0.14−0.01 (-3.84%)
Close on Nov 19, 2026Market cap $9.67MP/E –Yield –
Fundamental chart
Pick a measure to chart its full history
$10.33MFY2025, +56.9% a year since FY2020
See a number that looks wrong?